Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chromatin modification of melanoma cell line after CRISPRi-sgRNAs

ABSTRACT: Chromatin modification of melanoma cell line after CRISPRi-sgRNAs

PROVIDER: PRJNA1254967 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR33298600_1.fastq.gz	Fastqsanger.gz
	SRR33298600_2.fastq.gz	Fastqsanger.gz
	SRR33298601_1.fastq.gz	Fastqsanger.gz
	SRR33298601_2.fastq.gz	Fastqsanger.gz
	SRR33298602_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 82

Similar Datasets

Chromatin modification of melanoma cell line after CRISPRi-sgRNAs

Project description:Chromatin modification was studied using various histone modification marks after CRISPRi in 501mel

2025-05-01 | GSE295492 | GEO

iPSC RNA-seq upon CRISPRn or CRISPRi manipulation

Project description:Assess the on- and off-target effects of dox-inducible CRISPR/Cas9 and CRISPRi constructs in a human iPS cell line. Transcript quantification of 3 cell lines, each plus or minus doxycycline and with or without specific single guide RNAs (sgRNAs), with 2 biological replicates each.

2016-01-19 | E-GEOD-76980 | biostudies-arrayexpress

dCas9 level on chromatin to validate the specificity of CRISPRi-sgRNAs

Project description:dCas9 level on chromatin to validate the specificity of CRISPRi-sgRNAs

| PRJNA1254965 | ENA

Chromatin modification of melanoma cell line after knockdown of NIPBL

Project description:Chromatin modification of melanoma cell line after knockdown of NIPBL

| PRJNA971574 | ENA

dCas9 level on chromatin to validate the specificity of CRISPRi-sgRNAs

Project description:dCas9 level on chromatin was studied after CRISPRi

2025-05-01 | GSE295495 | GEO

RNA-seq of CSMD1 enhancer CRISPRi in LUHMES cells and differentiated neurons

Project description:we performed lentiviral CRISPR interference (CRISPRi) by recruiting dCas9 fused with the KRAB domain to the CSMD1 enhancer (fam3) in the neuronal precursor cell line – Lund human mesencephalic (LUHMES). Given that the expression of CSMD1 was not detectable in LUHMES cells we differentiated these cells into neurons. Differentiated neurons with CRISPRi of CSMD1 enhancer showed significantly higher expression of CSMD1 than control.

2022-06-30 | E-MTAB-8027 | biostudies-arrayexpress

Landscape of enhancer disruption and functional screen in melanoma [CRISPRi]

Project description:The high mutation rate across the whole melanoma genome provides a major challenge in stratifying true driver events from the background mutations. Many non-coding recurrent events, such as those occurred in enhancer, can shape tumor evolution, emphasizing the importance in systematically deciphering enhancer disruptions in melanoma. Here, we leveraged 297 melanoma whole-genome sequencing (WGS) samples to prioritize highly recurrent regions (HRRs). By performing a genome-scale CRISPR interference (CRISPRi) screen on HRR-associated enhancers in melanoma cells, we identified 66 significant hits which could have tumor-suppressive roles. These functional enhancers show unique mutational patterns independent of classical significantly mutated genes in melanoma. Target gene analysis for the essential enhancers revealed many known and hidden mechanisms underlying melanoma development. We demonstrated that a super enhancer element could modulate melanoma cell proliferation by targeting MEF2A and another distal enhancer was able to sustain PTEN tumor-suppressive potential via long-range interaction. Our study established a catalogue of crucial enhancers and their target genes in melanoma development and progression, which illuminates the identification of novel mechanism of dysregulation for melanoma driver genes and new therapeutic targeting strategy.

2023-10-11 | GSE210422 | GEO

Landscape of enhancer disruption and functional screen in melanoma [CRISPRi]

Project description:Landscape of enhancer disruption and functional screen in melanoma [CRISPRi]

| PRJNA865708 | ENA

Knockdown CPT1 in NCI-H460 lung cancer cell line

Project description:CRISPRi-mediated transcriptional inhibition of CPT1 with two distinct sgRNAs in NCI-H460 lung cancer cells, to investigate the dynamics of gene expression regulation upon CPT1 knockdown.

2024-05-28 | GSE268180 | GEO

Histone acetylation modification analysis in uveal melanoma cells and normal melanocytes.

Project description:In order to study the histone modification differences in uveal melanoma cells and normal melanocytes.

2020-12-03 | GSE162573 | GEO